β2-Microglobulin and β-Trace Protein in Patients Undergoing Bariatric Surgery: Non-GFR Determinants and Panel-estimated GFR Performance

Alex R. Chang; Jingsha Chen; Morgan E. Grams; Amy B. Karger; Lesley A. Inker; Josef Coresh; Andrew S. Levey

doi:10.1016/j.xkme.2021.10.013

β2-Microglobulin and β-Trace Protein in Patients Undergoing Bariatric Surgery: Non-GFR Determinants and Panel-estimated GFR Performance

Alex R. Chang, Jingsha Chen, Morgan E. Grams, Amy B. Karger, Lesley A. Inker, Josef Coresh, Andrew S. Levey

Laboratory Medicine and Pathology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Article number	100401
Journal	Kidney Medicine
Volume	4
Issue number	2
DOIs	https://doi.org/10.1016/j.xkme.2021.10.013
State	Published - Feb 2022

Bibliographical note

Funding Information:
Research idea and study design: ARC, MEG, LAI, JC, ASL; data acquisition: ARC; data analysis/interpretation: ARC, JCh, MEG, LAI, JCo, ASL, ABK; statistical analysis: JCh, JCo; supervision or mentorship: ASL, JCo, MEG. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual's own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate. Funding for this work was provided to Dr Chang by NIDDK K23DK106515. Dr Inker and Dr Levey were supported by NIDDK R01DK097020 and R01DK116790-01A1. Dr Grams was supported by NIDDK K24HL15586. Dr Karger has received research support from Siemens and is a consultant for Roche Diagnostics. Dr Levey receives research support from Siemens. The remaining authors declare that they have no relevant financial interests. We thank Avry Chagnac for reviewing a draft of this article. Received May 26, 2021, as a submission to the expedited consideration track with 3 external peer reviews. Direct editorial input from an Editorial Board member (Lorien Dalrymple, MD, MPH) who served as Acting Editor-in-Chief. Accepted in revised form October 29, 2021. The involvement of an Acting Editor-in-Chief was to comply with Kidney Medicine's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies.

Funding Information:
Funding for this work was provided to Dr Chang by NIDDK K23DK106515. Dr Inker and Dr Levey were supported by NIDDK R01DK097020 and R01DK116790-01A1. Dr Grams was supported by NIDDK K24HL15586.

PubMed: MeSH publication types

Journal Article

Access

10.1016/j.xkme.2021.10.013

OpenUrl availability

Full text

Cite this

@article{3186fdfc11374fd7add5c31e9a5a30a2,

title = "β2-Microglobulin and β-Trace Protein in Patients Undergoing Bariatric Surgery: Non-GFR Determinants and Panel-estimated GFR Performance",

author = "Chang, {Alex R.} and Jingsha Chen and Grams, {Morgan E.} and Karger, {Amy B.} and Inker, {Lesley A.} and Josef Coresh and Levey, {Andrew S.}",

note = "Funding Information: Research idea and study design: ARC, MEG, LAI, JC, ASL; data acquisition: ARC; data analysis/interpretation: ARC, JCh, MEG, LAI, JCo, ASL, ABK; statistical analysis: JCh, JCo; supervision or mentorship: ASL, JCo, MEG. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual's own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate. Funding for this work was provided to Dr Chang by NIDDK K23DK106515. Dr Inker and Dr Levey were supported by NIDDK R01DK097020 and R01DK116790-01A1. Dr Grams was supported by NIDDK K24HL15586. Dr Karger has received research support from Siemens and is a consultant for Roche Diagnostics. Dr Levey receives research support from Siemens. The remaining authors declare that they have no relevant financial interests. We thank Avry Chagnac for reviewing a draft of this article. Received May 26, 2021, as a submission to the expedited consideration track with 3 external peer reviews. Direct editorial input from an Editorial Board member (Lorien Dalrymple, MD, MPH) who served as Acting Editor-in-Chief. Accepted in revised form October 29, 2021. The involvement of an Acting Editor-in-Chief was to comply with Kidney Medicine's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies. Funding Information: Funding for this work was provided to Dr Chang by NIDDK K23DK106515. Dr Inker and Dr Levey were supported by NIDDK R01DK097020 and R01DK116790-01A1. Dr Grams was supported by NIDDK K24HL15586. ",

year = "2022",

month = feb,

doi = "10.1016/j.xkme.2021.10.013",

language = "English (US)",

volume = "4",

journal = "Kidney Medicine",

issn = "2590-0595",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - β2-Microglobulin and β-Trace Protein in Patients Undergoing Bariatric Surgery

T2 - Non-GFR Determinants and Panel-estimated GFR Performance

AU - Chang, Alex R.

AU - Chen, Jingsha

AU - Grams, Morgan E.

AU - Karger, Amy B.

AU - Inker, Lesley A.

AU - Coresh, Josef

AU - Levey, Andrew S.

N1 - Funding Information: Research idea and study design: ARC, MEG, LAI, JC, ASL; data acquisition: ARC; data analysis/interpretation: ARC, JCh, MEG, LAI, JCo, ASL, ABK; statistical analysis: JCh, JCo; supervision or mentorship: ASL, JCo, MEG. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual's own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate. Funding for this work was provided to Dr Chang by NIDDK K23DK106515. Dr Inker and Dr Levey were supported by NIDDK R01DK097020 and R01DK116790-01A1. Dr Grams was supported by NIDDK K24HL15586. Dr Karger has received research support from Siemens and is a consultant for Roche Diagnostics. Dr Levey receives research support from Siemens. The remaining authors declare that they have no relevant financial interests. We thank Avry Chagnac for reviewing a draft of this article. Received May 26, 2021, as a submission to the expedited consideration track with 3 external peer reviews. Direct editorial input from an Editorial Board member (Lorien Dalrymple, MD, MPH) who served as Acting Editor-in-Chief. Accepted in revised form October 29, 2021. The involvement of an Acting Editor-in-Chief was to comply with Kidney Medicine's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies. Funding Information: Funding for this work was provided to Dr Chang by NIDDK K23DK106515. Dr Inker and Dr Levey were supported by NIDDK R01DK097020 and R01DK116790-01A1. Dr Grams was supported by NIDDK K24HL15586.

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85123678696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123678696&partnerID=8YFLogxK

U2 - 10.1016/j.xkme.2021.10.013

DO - 10.1016/j.xkme.2021.10.013

M3 - Article

C2 - 35243311

AN - SCOPUS:85123678696

SN - 2590-0595

VL - 4

JO - Kidney Medicine

JF - Kidney Medicine

IS - 2

M1 - 100401

ER -

β2-Microglobulin and β-Trace Protein in Patients Undergoing Bariatric Surgery: Non-GFR Determinants and Panel-estimated GFR Performance

Bibliographical note

PubMed: MeSH publication types

Access

OpenUrl availability

Other files and links

Cite this